Follow MRNA's call journal

Get an email when MRNA calls are scored, or follow MRNA in the iPhone app. The file on this page stays readable without an account.

Email me when MRNA calls resolve

When a tracked MRNA call is scored — hit, miss or partial — we’ll email you the result. No account needed.

Used only for these updates. Privacy

Follow MRNA in the iPhone app

Asset spotlight

What was said about Moderna

Creator calls, with the evidence to check them.

MRNA · latest price

$254.19

as of 20h ago

See the track record Read the calls Add holding

The YouTube conversation

What are creators saying?

Selected calls on file

Recorded calls: 4
YouTube channels: 2
Pending outcomes: 1

3 bullish
1 bearish

30 / 90 days · price direction

Directional track record

Did price move in the direction of the call?

Separate from forecast accuracy.

30-day window

1 matched

of 1 observed call

Rate appears from 10 observations

0 waiting for the window

0 missing price evidence

Inspect the calls

Matched: 1
Moved opposite: 0
Flat: 0
Waiting for the window: 0
Missing price evidence: 0
Average direction-adjusted move: +19.2%
Published calls on file: 4
Excluded from this measurement: 2
Additional calls grouped: 1

One observation per creator, asset and UTC publication day. Conflicting directions on the same day are excluded. Flat observations stay in the denominator. Waiting windows and missing evidence are unknown outcomes.

Example measured calls

Randy Kirk · MRNADirection matched
Bullish call · published Aug 20, 2026
Entry close · Aug 21, 2026
$145.13
End close · Sep 21, 2026
$172.94
Price change +19.2% · Direction-adjusted +19.2%

90-day window

0 matched

of 0 observed calls

Rate appears from 10 observations

1 waiting for the window

0 missing price evidence

Inspect the calls

Matched: 0
Moved opposite: 0
Flat: 0
Waiting for the window: 1
Missing price evidence: 0
Published calls on file: 4
Excluded from this measurement: 2
Additional calls grouped: 1

No measured calls available yet.

How to read this

Direction is extracted by AI and may need correction. These fixed windows do not evaluate the creator’s own target or deadline. The entry is the first full market session after the source’s UTC publication date; we compare its close with the close 30 or 90 calendar days later, rolling a non-trading endpoint forward. Bullish calls match a rise; bearish calls match a fall. This is a price comparison, not a trading return.

How directional measurements work

Updated Nov 7, 2026

Forecast accuracy

Creators’ own targets and deadlines

—

nothing resolved yet

4 calls from 2 channels are on file for MRNA. None have resolved yet, so there is no hit rate to report. 1 is still pending. The record leans bullish: 3 bullish and 1 bearish.

This is the weighted hit rate: a partial counts as half. It uses resolved forecasts, not the 30/90-day directional observations above.

How hit rates work

Email me when MRNA calls resolve

When a tracked MRNA call is scored — hit, miss or partial — we’ll email you the result. No account needed.

Used only for these updates. Privacy

Follow MRNA in the iPhone app

Price & targets

Compare one creator’s call at a time.

Choose a target

2 targets available · newest first

Daily close
Selected target

Recent daily closes through Nov 6, 2026. Price history is incomplete; gaps remain open.

Meet Kevin

Said Oct 20, 2026

Price target

$140

BearishRecorded outcomeNot scored

Deadline: Deadline not recorded

Open call & evidence

Call context

Stated timeframe: Conditional on a disappointing presentation this Saturday, October 24; no explicit price deadline.

Original words

“this meeting on Saturday could go horrible for Mona and then it's $140 stock again and you've lost all your gains.”

Source video

About this view

Price window: May 11, 2026–Nov 6, 2026. Yahoo Finance · daily closes. Prices and targets use split-adjusted units.

92 trading sessions are missing from this window. Lines break across missing sessions; one observation appears as a dot.

The recorded outcome follows the call’s original target, deadline and conditions. The price line shows daily closing observations.

2 calls lack a comparable target or source date. Find calls without targets in the creator archive.

Calls, by channel

Choose a creator to read their calls and source evidence.

Meet Kevin3 callsBullish

Kevin identifies Moderna alongside Eli Lilly as a current healthcare rotation opportunity. He cites gains on earlier Moderna purchases as evidence of capital moving toward healthcare.

Most recent thesisOct 30, 2026Source video

Kevin identifies Moderna alongside Eli Lilly as a current healthcare rotation opportunity. He cites gains on earlier Moderna purchases as evidence of capital moving toward healthcare.

Earlier thesis (1)

BullishOct 20, 2026Source

The host is enthusiastic about Moderna's personalized cancer therapy and the potential for AI to accelerate treatment development and broaden access. He presents the October 24 presentation as a major catalyst with sharply different upside and downside outcomes.

BullNot scoredNo targetOct 30, 2026

“Our target was, unless that happens for rate-sensitives, healthcare on a rotation side, here we are again, and we specifically point out El…”

Bullpending$300Oct 20, 2026

“And it could also go great and it's a $300 stock.”

BearNot scored$140Oct 20, 2026

“this meeting on Saturday could go horrible for Mona and then it's $140 stock again and you've lost all your gains.”

Randy Kirk1 callBullish

The hosts discuss Moderna's mRNA cancer treatment breakthrough that reduced high-risk cancer recurrence, noting the stock roughly doubled to tripled on the news. They frame this as the start of a broader 'ChatGPT moment' for AI applied to medicine that could pull in massive R&D investment from big pharma.

Most recent thesisAug 20, 2026Source video

BullNot scoredNo targetAug 20, 2026

“Madna you know had a double almost a triple on their stock and could go even higher right that being able to win on AI applied to medicine…”